Postoperative pain
Conditions
Interventions
Group C:20 ml 0.5% Ropivacaine
Group RD1:20ml 0.5% Ropivacaine combined with 0.5 µ g / kg Dextromethopyrimidine
Group RD2:20ml 0.5% Ropivacaine combined with 1 µ g / kg Dextromethopyrimidine
Sponsors
Ordos Central Hospital, Inner Mongolia
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Aged 40-65 years; 2. American Society of anesthesiologists (ASA) grade I or II; 3. Breast cancer diagnosed by pathology; 4. General anesthesia combined with anterior saw nerve block during operation.
Exclusion criteria
Exclusion criteria: 1. Chronic renal failure (glomerular filtration rate 30 kg·m–2); 6. Allergy to drugs used in the study; 7. Operation time 3 h.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total sufentanil consumption 48 hours after operation; | — |
Secondary
| Measure | Time frame |
|---|---|
| ????? Hemodynamics;Pain intensity;Functional activity score;Level of Sedation;Bruggrmann comfort scale;Demand for vasoactive drugs;PACU and hospital stay;Patient and surgeon satisfaction scores;Incidence of chronic pain 3 months after surgery; | — |
Countries
China
Contacts
Public ContactCaiping Duan
Ordos Central Hospital, Inner Mongolia
Outcome results
None listed